Speaker illustration

Doctor Eva Berghausen

University of Cologne, Cologne (Germany)

Selective inhibition of the PI3K isoform p110alpha using BYL719 protects against tyrosine kinase-mediated processes in PASMCs and reduces experimental pulmonary hypertension in mice and rats

Event: ESC Congress 2021 - The Digital Experience

Topic: Hypertension, Pulmonary Hypertension

Session: Basic science e-posters

Thumbnail

In vitro characterization of a novel PI 3-kinase inhibitor for growth factor-induced effects in pulmonary artery smooth muscle cells

Event: ESC Congress 2019

Topic: Hypertension, Pulmonary Hypertension

Session: Vascular signalling

Thumbnail

PI3Kdelta mediates growth factor induced PASMC proliferation and hypoxia induced pulmonary hypertension via non-catalytic mechanisms

Event: ESC Congress 2016

Topic: Vascular remodelling

Session: Vascular biology and remodelling

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb